Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia (COVID-19EXO2)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04602442|
Recruitment Status : Unknown
Verified October 2020 by Olga Tyumina, State-Financed Health Facility "Samara Regional Medical Center Dinasty".
Recruitment status was: Enrolling by invitation
First Posted : October 26, 2020
Last Update Posted : October 26, 2020
Clinics of the Federal State Budgetary Educational Institution SSMU
Samara Regional Clinical Hospital V.D. Seredavin
Information provided by (Responsible Party):
Olga Tyumina, State-Financed Health Facility "Samara Regional Medical Center Dinasty"
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||August 1, 2021|
|Estimated Study Completion Date :||December 30, 2021|